Complete Filing Data
Centessa Pharmaceuticals plc reported Stockholders Equity of $526.86 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Centessa Pharmaceuticals plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $1.0M | $1.2M | $1.7M | -$2.2M | $778.0K | -$240.0K | $412.0K |
| Net Income Loss | -$197.5M | -$235.8M | -$151.1M | -$216.2M | -$381.1M | -$10.7M | -$5.1M |
| Research And Development Expense Excluding Acquired In Process Cost | $172.2M | $150.2M | $124.4M | $155.1M | $95.7M | $9.3M | $4.3M |
| Other Nonoperating Income Expense | $2.9M | -$1.7M | -$5.4M | $2.3M | -$4.4M | $155.0K | $105.0K |
| Operating Income Loss | -$207.7M | -$201.1M | -$171.3M | -$212.3M | -$374.1M | -$10.4M | -$5.1M |
| General And Administrative Expense | $50.5M | $50.8M | $53.7M | $55.2M | $42.9M | $1.1M | $790.0K |
| Comprehensive Income Net Of Tax | -$199.0M | -$233.0M | -$148.1M | -$218.4M | -$380.3M | -$10.9M | -$4.6M |
| Income Tax Expense Benefit | $1.8M | $2.8M | -$25.1M | -$747.0K | $114.0K | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$195.7M | -$232.9M | -$176.1M | -$217.0M | -$381.0M | -$10.7M | -$5.1M |
| Interest Income Expense Nonoperating Net | $10.5M | $244.0K | -$1.2M | -$68.0K | $5.0K | ||
| Income Taxes Paid | $1.3M | $82.0K | $2.9M | $1.3M | $0.00 | ||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$1.5M | $2.7M | $3.0M | ||||
| Research And Development In Process | $0.00 | $220.5M | $0.00 | $0.00 | |||
| Deferred Income Tax Expense Benefit | $2.5M | $2.7M | -$26.5M | -$2.9M | |||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $1.5M | $1.3M | $0.00 | ||||
| Interest Expense Nonoperating | $11.5M | $10.1M | $9.9M | ||||
| Deferred Income Tax Assets Net | $24.8M | $26.6M | $29.6M | $3.5M | |||
| Revenues | $15.0M | $0.00 | $6.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $691.0K | -$479.0K | $643.0K | -$412.0K | -$61.0K | -$25.0K | -$419.0K | $762.0K | $898.0K | -$553.0K | -$1.1M | -$706.0K | -$487.0K | $1.1M | $2.2M | -$240.0K | $372.0K | -$25.0K | -$707.0K |
| Net Income Loss | -$54.9M | -$50.3M | -$26.1M | -$42.6M | -$43.8M | -$38.0M | -$38.6M | -$24.9M | -$50.7M | -$53.9M | -$64.7M | -$54.5M | -$40.2M | -$41.5M | -$238.7M | -$10.7M | -$2.1M | -$2.2M | -$3.0M |
| Research And Development Expense Excluding Acquired In Process Cost | $41.6M | $42.7M | $33.4M | $33.9M | $32.8M | $22.7M | $28.2M | $33.7M | $32.8M | $36.7M | $53.7M | $36.9M | $25.9M | $18.1M | $10.1M | $1.9M | $1.9M | ||
| Other Nonoperating Income Expense | -$1.8M | $3.6M | $1.0M | $3.7M | $154.0K | -$1.5M | -$1.7M | -$1.5M | -$1.3M | -$3.1M | $5.4M | $196.0K | -$1.9M | -$191.0K | -$2.5M | $6.0K | -$10.0K | ||
| Operating Income Loss | -$53.8M | -$54.7M | -$30.8M | -$46.4M | -$44.0M | -$36.1M | -$40.2M | -$47.0M | -$48.9M | -$49.0M | -$68.4M | -$53.2M | -$38.3M | -$41.3M | -$236.2M | -$2.1M | -$2.1M | ||
| General And Administrative Expense | $12.2M | $11.9M | $12.3M | $12.5M | $11.2M | $13.4M | $12.0M | $13.3M | $16.1M | $12.3M | $14.8M | $14.4M | $12.5M | $11.8M | $5.6M | $193.0K | $258.0K | ||
| Comprehensive Income Net Of Tax | -$53.9M | -$50.8M | -$28.3M | -$42.1M | -$43.8M | -$37.9M | -$38.8M | -$23.3M | -$49.8M | -$54.4M | -$65.8M | -$55.2M | -$40.6M | -$40.4M | -$236.5M | -$1.8M | -$2.3M | ||
| Income Tax Expense Benefit | $166.0K | $778.0K | $1.4M | $608.0K | $705.0K | $481.0K | -$2.8M | -$24.1M | $677.0K | -$141.0K | -$22.0K | $80.0K | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$54.7M | -$49.6M | -$24.7M | -$42.0M | -$43.1M | -$37.6M | -$41.5M | -$48.9M | -$50.0M | -$54.0M | -$64.7M | -$54.4M | -$40.2M | -$41.5M | -$238.7M | ||||
| Interest Income Expense Nonoperating Net | $2.6M | $3.0M | $2.1M | $2.5M | $77.0K | $25.0K | $104.0K | $65.0K | $27.0K | $8.0K | -$22.0K | -$17.0K | |||||||
| Income Taxes Paid | $0.00 | $0.00 | $135.0K | $0.00 | |||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $1.0M | -$484.0K | -$2.1M | $500.0K | -$28.0K | $130.0K | -$167.0K | $1.5M | $898.0K | -$553.0K | -$1.1M | ||||||||
| Research And Development In Process | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $220.5M | $0.00 | $0.00 | |||||||||||
| Deferred Income Tax Expense Benefit | $995.0K | $434.0K | $0.00 | ||||||||||||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $912.0K | $33.0K | $155.0K | $252.0K | $783.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Interest Expense Nonoperating | $2.9M | $2.9M | $2.9M | $2.6M | $2.5M | $2.5M | $2.5M | $2.5M | |||||||||||
| Deferred Income Tax Assets Net | $25.0M | $25.4M | $26.4M | $27.1M | $28.6M | $29.2M | $29.6M | $26.8M | |||||||||||
| Revenues | $0.00 | $0.00 | $15.0M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $526.9M | $401.5M | $236.2M | $336.2M | $491.6M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $62.0M | $383.2M | $128.0M | $393.6M | $595.1M | $7.2M | $16.6M | $12.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$321.3M | $255.2M | -$265.6M | -$201.4M | $590.1M | -$9.3M | $3.7M | |
| Asset Acquisition Contingent Consideration Liability Gain Loss From Change In Fair Value | $0.00 | $2.0M | $15.1M | $0.00 | $0.00 | |||
| Tax Incentive Receivable Current | $53.9M | $43.8M | $37.8M | $24.2M | $15.4M | $2.6M | ||
| Property Plant And Equipment Net | $807.0K | $744.0K | $1.0M | $1.2M | $162.0K | $0.00 | ||
| Prepaid Expense And Other Assets Current | $19.4M | $10.5M | $20.7M | $19.9M | $18.3M | $1.3M | ||
| Liabilities Current | $42.9M | $58.0M | $39.4M | $38.3M | $24.6M | $8.6M | ||
| Liabilities And Stockholders Equity | $687.5M | $576.8M | $360.2M | $444.3M | $629.6M | $11.7M | ||
| Liabilities | $160.6M | $175.3M | $124.0M | $108.1M | $138.1M | $8.6M | ||
| Cash And Cash Equivalents At Carrying Value | $61.3M | $383.2M | $128.0M | $393.6M | $595.1M | $7.2M | ||
| Assets Current | $367.9M | $536.4M | $315.1M | $437.7M | $628.8M | $11.2M | ||
| Assets | $687.5M | $576.8M | $360.2M | $444.3M | $629.6M | $11.7M | ||
| Accrued Liabilities Current | $35.4M | $50.9M | $27.6M | $24.5M | $16.6M | $1.0M | ||
| Accounts Payable Current | $7.6M | $7.1M | $11.8M | $13.8M | $8.1M | $1.0M | ||
| Retained Earnings Accumulated Deficit | -$1.19B | -$988.7M | -$752.9M | -$601.9M | -$385.7M | |||
| Common Stock Value | $405.0K | $359.0K | $273.0K | $265.0K | $252.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.7M | $4.2M | $1.5M | -$1.5M | $688.0K | |||
| Long Term Debt Noncurrent | $110.1M | $108.9M | $75.7M | $69.8M | $75.7M | $0.00 | ||
| Other Operating Activities Cash Flow Statement | -$8.0K | $62.0K | $28.0K | $173.0K | $676.0K | $57.0K | $60.0K | |
| Amortization Of Debt Discount Premium | $0.00 | $0.00 | $310.0K | $118.0K | ||||
| Other Liabilities Noncurrent | $29.0K | $29.0K | $29.0K | $0.00 | $43.0K | $0.00 | ||
| Other Assets Noncurrent | $1.4M | $2.0M | $2.6M | $1.9M | $699.0K | $552.0K | ||
| Short Term Investments | $233.3M | $99.0M | $128.5M | $0.00 | ||||
| Operating Lease Right Of Use Asset | $10.0M | $11.0M | $11.9M | $0.00 | ||||
| Operating Lease Liability Noncurrent | $7.6M | $8.3M | $8.9M | $0.00 | ||||
| Members Equity | -$23.1M | -$22.4M | -$11.9M | -$7.5M | ||||
| Operating Lease Payments | $1.6M | $1.6M | $1.2M | $0.00 | ||||
| Debt Instrument Decrease Forgiveness | $0.00 | $6.2M | $0.00 | $0.00 | ||||
| Debt Conversion Converted Instrument Amount1 | $0.00 | $6.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $301.6M | $344.9M | $386.2M | $499.1M | $287.0M | $215.2M | $259.4M | $276.6M | $293.3M | $372.9M | $420.0M | $480.2M | $549.1M | $585.6M | $278.6M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $50.8M | $44.2M | $105.2M | $395.0M | $127.4M | $118.2M | $171.5M | $145.2M | $260.0M | $444.8M | $484.2M | $544.5M | $578.8M | $613.8M | $298.6M | $8.9M | $10.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$278.1M | -$9.8M | -$133.7M | -$50.6M | $293.6M | ||||||||||||||
| Asset Acquisition Contingent Consideration Liability Gain Loss From Change In Fair Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.0M | $0.00 | $11.3M | $0.00 | $0.00 | $0.00 | ||||||||
| Tax Incentive Receivable Current | $49.1M | $40.7M | $49.6M | $34.0M | $41.9M | $36.3M | $28.5M | $27.2M | $20.3M | $20.0M | $18.9M | $20.6M | $18.6M | $13.9M | |||||
| Property Plant And Equipment Net | $894.0K | $733.0K | $681.0K | $821.0K | $903.0K | $952.0K | $1.1M | $1.1M | $1.2M | $552.0K | $905.0K | $374.0K | $114.0K | $74.8K | |||||
| Prepaid Expense And Other Assets Current | $12.3M | $8.9M | $13.6M | $15.9M | $18.8M | $18.0M | $22.7M | $19.7M | $17.8M | $12.2M | $16.4M | $16.1M | $14.2M | $16.0M | |||||
| Liabilities Current | $29.1M | $29.7M | $24.2M | $26.4M | $26.8M | $27.4M | $35.0M | $33.9M | $29.7M | $38.2M | $33.6M | $27.2M | $29.1M | $24.2M | |||||
| Liabilities And Stockholders Equity | $448.3M | $492.1M | $527.8M | $609.7M | $398.8M | $328.2M | $377.4M | $392.9M | $403.9M | $479.4M | $521.1M | $582.2M | $612.2M | $643.8M | |||||
| Liabilities | $146.7M | $147.2M | $141.6M | $110.6M | $111.9M | $113.0M | $118.0M | $116.3M | $110.6M | $106.4M | $101.0M | $102.0M | $63.1M | $58.1M | |||||
| Cash And Cash Equivalents At Carrying Value | $50.8M | $44.2M | $105.2M | $395.0M | $127.4M | $118.2M | $171.5M | $145.2M | $260.0M | $444.8M | $484.2M | $544.5M | $578.8M | $613.8M | |||||
| Assets Current | $307.7M | $300.4M | $347.7M | $568.4M | $355.5M | $284.5M | $332.5M | $350.4M | $384.3M | $477.0M | $519.5M | $581.2M | $611.6M | $643.7M | |||||
| Assets | $448.3M | $492.1M | $527.8M | $609.7M | $398.8M | $328.2M | $377.4M | $392.9M | $403.9M | $479.4M | $521.1M | $582.2M | $612.2M | $643.8M | |||||
| Accrued Liabilities Current | $20.4M | $24.0M | $19.1M | $19.0M | $21.4M | $19.9M | $24.1M | $22.8M | $15.3M | $27.3M | $25.3M | $20.5M | $10.7M | $16.9M | |||||
| Accounts Payable Current | $8.7M | $5.7M | $5.1M | $7.4M | $5.3M | $7.5M | $10.8M | $11.1M | $14.4M | $10.9M | $8.2M | $6.7M | $18.5M | $7.3M | |||||
| Retained Earnings Accumulated Deficit | -$1.12B | -$1.07B | -$1.01B | -$877.4M | -$834.8M | -$791.0M | -$716.1M | -$677.5M | -$652.6M | -$558.7M | -$504.8M | -$440.2M | -$324.9M | -$284.7M | |||||
| Common Stock Value | $364.0K | $363.0K | $362.0K | $357.0K | $309.0K | $277.0K | $271.0K | $266.0K | $266.0K | $263.0K | $263.0K | $262.0K | $252.0K | $252.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.6M | $1.6M | $2.1M | $2.1M | $1.6M | $1.6M | $779.0K | $946.0K | -$599.0K | -$1.7M | -$1.1M | -$18.0K | $2.7M | $3.2M | |||||
| Long Term Debt Noncurrent | $109.8M | $109.5M | $109.3M | $75.7M | $76.5M | $76.8M | $74.0M | $73.3M | $71.6M | $68.2M | $67.4M | $74.8M | |||||||
| Other Operating Activities Cash Flow Statement | $103.0K | $0.00 | -$825.0K | $0.00 | $7.0K | ||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $78.0K | $72.0K | |||||||||||
| Other Liabilities Noncurrent | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $43.0K | $43.0K | $43.0K | ||||||||||
| Other Assets Noncurrent | $1.6M | $1.7M | $1.9M | $2.2M | $2.4M | $1.9M | $2.1M | $2.3M | $6.0M | ||||||||||
| Short Term Investments | $195.4M | $206.5M | $179.3M | $123.4M | $167.5M | $112.0M | $109.8M | $158.4M | $86.2M | ||||||||||
| Operating Lease Right Of Use Asset | $10.3M | $10.5M | $10.8M | $11.2M | $11.5M | $11.7M | $12.1M | $12.3M | $12.3M | ||||||||||
| Operating Lease Liability Noncurrent | $7.8M | $7.9M | $8.1M | $8.4M | $8.6M | $8.7M | $9.0M | $9.1M | $9.3M | ||||||||||
| Members Equity | -$22.4M | -$19.3M | -$17.6M | -$15.5M | |||||||||||||||
| Operating Lease Payments | $408.0K | $400.0K | $0.00 | ||||||||||||||||
| Debt Instrument Decrease Forgiveness | $0.00 | $6.2M | |||||||||||||||||
| Debt Conversion Converted Instrument Amount1 | $0.00 | $6.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $31.0M | $33.5M | $29.4M | $25.0M | $14.9M | $336.0K | $236.0K |
| Proceeds From Stock Options Exercised | $21.4M | $11.2M | $310.0K | $718.0K | $779.0K | $0.00 | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$193.8M | -$142.1M | -$160.3M | -$200.5M | -$135.1M | -$10.6M | -$5.8M |
| Net Cash Provided By Used In Investing Activities | -$418.5M | $31.3M | -$127.0M | -$931.0K | $63.3M | $0.00 | $0.00 |
| Net Cash Provided By Used In Financing Activities | $291.5M | $364.8M | $21.1M | $457.0K | $660.1M | $1.4M | $9.0M |
| Increase Decrease In Tax Incentive Receivables | $7.3M | $6.6M | $12.1M | $11.7M | $6.8M | $1.5M | $647.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $7.9M | -$10.2M | $1.4M | $3.7M | $16.2M | -$306.0K | $1.4M |
| Increase Decrease In Accrued Liabilities | -$15.2M | $22.8M | -$797.0K | $6.3M | $13.0M | $653.0K | $123.0K |
| Increase Decrease In Accounts Payable | $50.0K | -$4.6M | -$2.7M | $6.4M | $4.2M | -$49.0K | $855.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$448.0K | $1.2M | $615.0K | -$418.0K | $1.8M | -$75.0K | $520.0K |
| Depreciation Depletion And Amortization | $921.0K | $942.0K | $810.0K | $131.0K | $34.0K | $0.00 | $6.0K |
| Payments To Acquire Property Plant And Equipment | $371.0K | $34.0K | $169.0K | $1.1M | $186.0K | $0.00 | $0.00 |
| Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Aggregate Intrinsic Value Vested | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Adjustments Related To Tax Withholding For Share Based Compensation | $3.3M | $6.1M | $2.3M | $505.0K | |||
| Proceeds From Payments For Other Financing Activities | -$401.0K | $0.00 | $0.00 | -$261.0K | -$295.0K | ||
| Payments To Acquire Marketable Securities | $739.8M | $140.5M | $264.9M | $0.00 | |||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $241.6M | $0.00 | $5.2M | |||
| Increase Decrease In Operating Lease Liability | $253.0K | $298.0K | -$1.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $7.9M | $8.2M | $7.2M | $5.7M | $2.7M | |||||||
| Proceeds From Stock Options Exercised | $1.8M | $838.0K | $0.00 | $335.0K | $292.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$57.2M | -$37.3M | -$47.8M | -$50.0M | -$11.6M | |||||||
| Net Cash Provided By Used In Investing Activities | -$222.4M | $16.8M | -$86.3M | -$240.0K | $63.5M | |||||||
| Net Cash Provided By Used In Financing Activities | $3.1M | $10.5M | $0.00 | $74.0K | $241.9M | |||||||
| Increase Decrease In Tax Incentive Receivables | $4.3M | -$1.2M | -$4.3M | $5.7M | $1.9M | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.7M | -$3.2M | -$1.1M | -$2.0M | $1.8M | |||||||
| Increase Decrease In Accrued Liabilities | -$29.6M | -$9.4M | -$9.8M | $2.6M | $998.0K | |||||||
| Increase Decrease In Accounts Payable | -$2.1M | -$4.3M | -$1.8M | -$1.2M | $6.5M | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.5M | $219.0K | $518.0K | -$434.0K | -$124.0K | |||||||
| Depreciation Depletion And Amortization | $217.0K | $240.0K | $89.0K | $28.0K | $2.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $88.0K | $240.0K | $37.0K | ||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Aggregate Intrinsic Value Vested | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $125.0K | $97.0K | $2.9M | $1.6M | $929.0K | $1.9M | $701.0K | $542.0K | $282.0K | |||
| Proceeds From Payments For Other Financing Activities | -$4.8M | $0.00 | $0.00 | -$261.0K | ||||||||
| Payments To Acquire Marketable Securities | $297.5M | $20.0M | $86.2M | $0.00 | ||||||||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $241.6M | ||||||||||
| Increase Decrease In Operating Lease Liability | $65.0K | $76.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 135.7M | 114.5M | 96.2M | 93.4M | 75.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 135.7M | 114.5M | 96.2M | 93.4M | 75.2M | |
| Earnings Per Share Diluted | $-1.46 | $-2.06 | $-1.57 | $-2.31 | $-5.07 | |
| Earnings Per Share Basic | $-1.46 | $-2.06 | $-1.57 | $-2.31 | $-5.07 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 149.2M | 132.6M | 98.8M | 94.8M | 90.0M | 0.00 |
| Common Stock Shares Issued | 149.2M | 132.6M | 98.8M | 94.8M | 90.0M | 0.00 |
| Common Stock Shares Authorized | 184.5M | 184.5M | 184.5M | 152.5M | 152.5M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 134.2M | 133.7M | 133.0M | 116.3M | 109.5M | 99.9M | 96.6M | 95.2M | 94.9M | 94.3M | 94.1M | 90.5M | 89.9M | 63.5M | 48.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 134.2M | 133.7M | 133.0M | 116.3M | 109.5M | 99.9M | 96.6M | 95.2M | 94.9M | 94.3M | 94.1M | 90.5M | 89.9M | 63.5M | 48.1M |
| Earnings Per Share Diluted | $-0.41 | $-0.38 | $-0.20 | $-0.37 | $-0.40 | $-0.38 | $-0.40 | $-0.26 | $-0.53 | $-0.57 | $-0.69 | $-0.60 | $-0.45 | $-0.65 | $-4.97 |
| Earnings Per Share Basic | $-0.41 | $-0.38 | $-0.20 | $-0.37 | $-0.40 | $-0.38 | $-0.40 | $-0.26 | $-0.53 | $-0.57 | $-0.69 | $-0.60 | $-0.45 | $-0.65 | $-4.97 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 134.4M | 133.9M | 133.6M | 131.7M | 113.2M | 100.5M | 97.6M | 95.3M | 95.1M | 94.6M | 94.3M | 94.0M | 89.9M | 89.9M | |
| Common Stock Shares Issued | 134.4M | 133.9M | 133.6M | 131.7M | 113.2M | 100.5M | 97.6M | 95.3M | 95.1M | 94.6M | 94.3M | 94.0M | 89.9M | 89.9M | |
| Common Stock Shares Authorized | 222.5M | 222.5M | 184.5M | 184.5M | 184.5M | 152.5M | 152.5M | 152.5M | 152.5M | 152.5M | 152.5M | 152.5M | 89.9M | 89.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $31.0M | $33.5M | $29.4M | $25.0M | $14.9M | $236.0K | |
| Stock Issued During Period Value Stock Options Exercised | $21.3M | $11.3M | $310.0K | $799.0K | $779.0K | ||
| Interest Paid Net | $9.5M | $10.1M | $9.9M | $7.3M | $1.5M | $0.00 | $0.00 |
| Additional Paid In Capital | $1.71B | $1.39B | $987.4M | $939.3M | $876.3M | ||
| Financial Instruments Gain Loss From Change In Fair Value | $0.00 | -$300.0K | -$5.9M | ||||
| Stock Issued1 | $0.00 | $262.7M | $0.00 | $0.00 | |||
| Investment Income Interest | $20.5M | $14.0M | $10.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.2M | $7.9M | $7.9M | $8.5M | $8.6M | $8.2M | $7.6M | $7.2M | $7.2M | $7.0M | $5.6M | $5.7M | $4.1M | $3.2M | $2.7M | $336.0K | $29.0K | $153.0K | $63.0K |
| Stock Issued During Period Value Stock Options Exercised | $3.5M | $1.6M | $1.9M | $4.7M | $692.0K | $955.0K | $177.0K | $15.0K | $283.0K | $70.0K | $335.0K | $292.0K | |||||||
| Interest Paid Net | $1.7M | $2.5M | $2.3M | $1.5M | $0.00 | ||||||||||||||
| Additional Paid In Capital | $1.42B | $1.41B | $1.40B | $1.37B | $1.12B | $1.00B | $974.4M | $952.9M | $946.2M | $933.0M | $925.7M | $920.1M | $871.0M | $866.9M | |||||
| Financial Instruments Gain Loss From Change In Fair Value | $0.00 | -$1.1M | -$1.8M | -$1.1M | $0.00 | ||||||||||||||
| Stock Issued1 | $0.00 | $262.7M | |||||||||||||||||
| Investment Income Interest | $3.8M | $4.4M | $7.9M | $3.3M | $3.2M | $2.6M | $3.0M | $2.1M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.